EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1) (C-Term) Peptide
Aperçu rapide pour EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1) (C-Term) Peptide (ABIN8099758)
Antigène
Origine
Source
Application
-
-
Protein Region
- C-Term
-
Fonction
- EPM2AIP1 Peptide - C-terminal region
-
Séquence
- EKAFSYLTRN QHTLSQPLTD EHLQALFRVA TTEMEPGWDD LVRERNESNP
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti- EPM2AIP1 Antibody (ARP79678_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
-
Sujet
- The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless.
-
Poids moléculaire
- 66 kDa
-
ID gène
- 9852
-
NCBI Accession
- NP_055620
-
UniProt
- Q7L775
Antigène
-